Perfusion Imaging Score to Predict Delayed Cerebral Ischemia
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: CTP scan, Neurological and neuropsychological testing.
- Who it may be relevant to
- Registry conditions: Aneurysmal Subarachnoid Hemorrhage, Cerebral Ischemia. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Aneurysmal subarachnoid hemorrhage (aSAH) is a significant public health concern, annually affecting over 30,000 Americans and ranking among the leading causes of stroke-related life-years lost in individuals aged 65 and younger. Delayed cerebral ischemia (DCI), occurring in 20% to 40% of aSAH survivors, is a major contributor to brain injury and disability. Timely recognition of DCI is crucial for improving neurological outcomes and preventing irreversible cerebral infarction. However, current methods have substantial limitations, hindering early and reliable detection. This proposal seeks to address these challenges through determining the ability of perfusion imaging to predict DCI and correlate with neurological and neuropsychological outcomes.
Detailed description
Patients with a diagnosis of aSAH and no early radiologic vasospasm on admission demonstrated by DSA will receive a CT Perfusion (CTP) scan within 48 hours of aSAH symptom onset. The researchers seek to determine whether these baseline scans will identify perfusion parameters predictive of DCI. At 12-months mark post-hemorrhage, neurological and neuropsychological tests will be conducted to determine whether perfusion imaging correlates with neurological and neuropsychological outcomes.
Interventions
- Radiation CTP scan
Patients with diagnosed aSAH and no evidence of early radiologic vasospasm will receive a CTP scan within 48 hours of aSAH symptom onset. - Diagnostic test Neurological and neuropsychological testing
All enrolled patients will receive neurological and neuropsychological assessment at 12 months after aSAH.
Primary outcome measures
- Occurrence of Delayed Cerebral Ischemia (DCI) [Time frame: During hospitalization (within 14 days of aneurysmal subarachnoid hemorrhage (aSAH))]
Secondary outcome measures (10)
- Correlation Between Baseline Perfusion Parameters and 12-Month Neurological Outcome [Time frame: 12 months post-aSAH]
- Modified Rankin Scale (mRS) [Time frame: 12 months post-aSAH]
- Health-Related Quality of Life (HRQoL, SF-36) [Time frame: 12 months post-aSAH]
- Global Mental Status - Montreal Cognitive Assessment (MoCA) [Time frame: 12 months post-aSAH]
- Executive Functioning - Wisconsin Card Sorting Test (WCST) [Time frame: 12 months post-aSAH]
- Processing Speed - Symbol Digit Modalities Test (SDMT) [Time frame: 12 months post-aSAH]
- Language - Boston Naming Test (BNT) [Time frame: 12 months post-aSAH]
- Verbal Fluency - FAS Test [Time frame: 12 months post-aSAH]
- Memory - Hopkins Verbal Learning Test-Revised (HVLT-R) [Time frame: 12 months post-aSAH]
- Composite Neuropsychological Test Scores [Time frame: 12 months post-aSAH]
Eligibility criteria
Inclusion criteria
- Age >18 years with a diagnosis of aSAH
Exclusion criteria
- chronic kidney disease stage IV
- pregnancy
- allergy to iodine that precludes CTP
- subjects with significant aphasia, blindness, or other factors that limit their participation in the cognitive assessment
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Diagnostic
Study locations
Center list to be confirmed — check the primary protocol.
Publications
- Dodd WS, Laurent D, Dumont AS, Hasan DM, Jabbour PM, Starke RM, Hosaka K, Polifka AJ, Hoh BL, Chalouhi N. Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review. J Am Heart Assoc. 2021 Aug 3;10(15):e021845. doi: 10.1161/JAHA.121.021845. Epub 2021 Jul 30. PMID 34325514
- Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014 Jan;10(1):44-58. doi: 10.1038/nrneurol.2013.246. Epub 2013 Dec 10. PMID 24323051
- Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pattinson KT. Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth. 2012 Sep;109(3):315-29. doi: 10.1093/bja/aes264. PMID 22879655
- Baumgartner RW. Transcranial color duplex sonography in cerebrovascular disease: a systematic review. Cerebrovasc Dis. 2003;16(1):4-13. doi: 10.1159/000070108. PMID 12766355
- Nguyen AM, Williamson CA, Pandey AS, Sheehan KM, Rajajee V. Screening Computed Tomography Angiography to Identify Patients at Low Risk for Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage. Front Neurol. 2021 Nov 12;12:740241. doi: 10.3389/fneur.2021.740241. eCollection 2021. PMID 34867722
- Mir DI, Gupta A, Dunning A, Puchi L, Robinson CL, Epstein HA, Sanelli PC. CT perfusion for detection of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2014 May;35(5):866-71. doi: 10.3174/ajnr.A3787. Epub 2013 Dec 5. PMID 24309123
- Starnoni D, Maduri R, Hajdu SD, Pierzchala K, Giammattei L, Rocca A, Grosfilley SB, Saliou G, Messerer M, Daniel RT. Early Perfusion Computed Tomography Scan for Prediction of Vasospasm and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2019 Oct;130:e743-e752. doi: 10.1016/j.wneu.2019.06.213. Epub 2019 Jul 5. PMID 31284055
- Bashir A, Andresen M, Bartek J Jr, Cortsen M, Eskesen V, Wagner A. Intra-arterial nimodipine for cerebral vasospasm after subarachnoid haemorrhage: Influence on clinical course and predictors of clinical outcome. Neuroradiol J. 2016 Feb;29(1):72-81. doi: 10.1177/1971400915626429. Epub 2016 Jan 29. PMID 26825134
Identifiers
NCT: NCT07030985 · 81412